Assume you are representing a U.S. firm in the pharmaceutical industry. You are assigned to develop an alliance with a Japanese pharmaceutical firm to coproduce a heart medicine. This medicine is one that your firm developed, but you want the alliance to result in the manufacturing of the product in Japan. What are the issues you want to discuss with the Japanese firm as you begin your negotiations? What are the concerns you have as you proceed in these negotiations?